- Global Operation
- Contract Manufacturing
The mechanism of action of Lurasidone in the treatment of schizophrenia and bipolar depression is unknown. However, its efficacy in schizophrenia and bipolar depression could be mediated through a combination of central dopamine Type 2 (D2) and serotonin Type-2 (5HT2A) receptor antagonism.
Lurasidone is indicated for:
• Depressive episodes associated with Bipolar disorder
Latuda® 20: Each box contains 30 tablets in Alu-Alu blister pack.
Latuda® 40: Each box contains 30 tablets in Alu-Alu blister pack.